Ru Shen
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Surfaces, Coatings and Films top 2%
- Polymer Surface Interaction Studies
Papers in
-
- Melanoma and MAPK Pathways 4
- Co-authors
- Allan Wissner (8 shared papers)Ramaswamy Nilakantan (8 shared papers)Hwei‐Ru Tsou (7 shared papers)Bernard D. Johnson (6 shared papers)Marvin F. Reich (5 shared papers)M. Brawner Floyd (7 shared papers)Carolyn Discafani (5 shared papers)Sridhar K. Rabindran (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Chinese Physics Letters (3 papers)Assay and Drug Development Technologies (3 papers)ACS Applied Materials & Interfaces (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ru Shen
67 papers receiving 2.9k citations
Ru Shen's Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 942
- Surfaces, Coatings and Films 229
- Organic Chemistry 646
- Biomaterials 294
- Genetics 162
Countries citing papers authored by Ru Shen
This map shows the geographic impact of Ru Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Shen more than expected).
Fields of papers citing papers by Ru Shen
This network shows the impact of papers produced by Ru Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Shen. The network helps show where Ru Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ru Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase Hit paper breakdown → | 2004 | 503 |
| 2 | 2005 | 246 | |
| 3 | 2001 | 227 | |
| 4 | 2002 | 212 | |
| 5 | 2000 | 183 | |
| 6 | 2013 | 165 | |
| 7 | 2010 | 124 | |
| 8 | 2014 | 121 | |
| 9 | 2018 | 88 | |
| 10 | 1999 | 84 | |
| 11 | 2020 | 67 | |
| 12 | 2017 | 59 | |
| 13 | 2015 | 56 | |
| 14 | 2002 | 54 | |
| 15 | 2006 | 52 | |
| 16 | 2011 | 50 | |
| 17 | 2019 | 49 | |
| 18 | 2016 | 43 | |
| 19 | 2018 | 41 | |
| 20 | 2017 | 38 |
About Ru Shen
Ru Shen is a scholar working on Molecular Biology, Materials Chemistry, Oncology, Biomedical Engineering and Organic Chemistry, having authored 71 papers that have together received 2.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Quinazolinone synthesis and applications (6 papers), Bone Tissue Engineering Materials (6 papers), Birth, Development, and Health (5 papers), Polymer Surface Interaction Studies (5 papers), Melanoma and MAPK Pathways (4 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Cardiac electrophysiology and arrhythmias (4 papers). The work is most often cited by research in Oncology (942 citations), Surfaces, Coatings and Films (229 citations), Organic Chemistry (646 citations), Biomaterials (294 citations) and Genetics (162 citations). Ru Shen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Allan Wissner, Ramaswamy Nilakantan, Hwei‐Ru Tsou, Bernard D. Johnson, Marvin F. Reich, M. Brawner Floyd, Carolyn Discafani, Sridhar K. Rabindran, Yu‐Fen Wang and Xiaoqing Shi. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Chinese Physics Letters, Assay and Drug Development Technologies and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.